224. Kawasaki Disease: What's New?
Saturday, October 7, 2017: 10:30 AM-12:00 PM
Room: 11AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the current status of establishing an etiology and diagnostic testing for Kawasaki Disease.
  • describe adjunctive and second/third line therapies that can be considered for Kawasaki Disease patients.
  • review recommendations for follow up of Kawasaki Disease patients based on degree of coronary artery involvement.

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists, Researchers

Tracks: Trainee, Pediatric ID

Chair:  Marsha Anderson, MD, FIDSA, University of Colorado SOM

Moderators:  Samuel Dominguez, MD, PhD, Childrens Hospital Colorado, University of Colorado SOM and Preeti Jaggi, MD, Nationwide Children's Hospital, The Ohio State University

10:55 AM
11:20 AM
11:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-310-L01-P


M. Anderson, None

S. Dominguez, None

P. Jaggi, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.